treatment murine colitis lactococcus lactis secreting interleukin-
cytokine interleukin il- shown promise clinical trials treatment inflammatory bower disease ibd using two mouse models show therapeutic dose il can reduced localized delivery bacterium genetically engineered secrete cytokine intragastric administration il--secreting lactococcus lactis caused % reduction colitis mice treated dextran sulfate sodium prevented onset colitis il--/- mice approach may lead better methods cost-effective long-term management ibd humans
